We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

353 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 112 increasing their positions, 119 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 43

4% more funds holding

Funds holding: 339 → 353 (+14)

6% less repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 119

11% less capital invested

Capital invested by funds: $6.45B → $5.72B (-$735M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

35% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $120M

Holders
353
Holders Change
+14
Holders Change %
+4.13%
% of All Funds
9.51%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
58
Increased
112
Reduced
119
Closed
43
Calls
$78.8M
Puts
$120M
Net Calls
-$41.7M
Net Calls Change
-$37.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$36.1M
2
CS
Credit Suisse
Switzerland
+$30.3M
3
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
+$29.1M
4
First Trust Advisors
First Trust Advisors
Illinois
+$25M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$24.7M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$126M
2
BA
BlackRock Advisors
Delaware
-$50.1M
3
EAM
Eagle Asset Management
Florida
-$46.5M
4
State Street
State Street
Massachusetts
-$42.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$42.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCA
151
Private Capital Advisors
Connecticut
$2.02M -$4.53M -71,220 -67%
MSTVIM
152
Messner & Smith Theme Value Investment Management
California
$1.98M +$851K +13,383 +64%
ID
153
Integral Derivatives
New York
$1.95M -$201K -3,161 -9%
FAF
154
Fjarde Ap-fonden
Sweden
$1.87M -$169K -2,653 -8%
Tudor Investment Corp
155
Tudor Investment Corp
Connecticut
$1.87M +$1.66M +26,117 +409%
JG
156
Jefferies Group
New York
$1.82M +$2.01M +31,573 New
CM
157
Castleark Management
Illinois
$1.71M -$7.51M -118,038 -80%
Commonwealth Equity Services
158
Commonwealth Equity Services
Massachusetts
$1.7M -$248K -3,904 -12%
Public Employees Retirement Association of Colorado
159
Public Employees Retirement Association of Colorado
Colorado
$1.67M +$151K +2,382 +9%
KFS
160
Kurt F. Somerville
$1.66M +$9.22K +145 +0.5%
DC
161
Davenport & Co
Virginia
$1.62M -$3.58M -56,300 -67%
FC
162
FIC Capital
New York
$1.56M -$70.9K -1,115 -4%
APG Asset Management
163
APG Asset Management
Netherlands
$1.53M +$1.7M +26,661 New
KBC Group
164
KBC Group
Belgium
$1.52M -$191K -3,004 -10%
PNC Financial Services Group
165
PNC Financial Services Group
Pennsylvania
$1.45M -$28.4K -446 -2%
LPL Financial
166
LPL Financial
California
$1.43M +$44.1K +693 +3%
Comerica Bank
167
Comerica Bank
Texas
$1.4M +$775K +12,187 +100%
Neuberger Berman Group
168
Neuberger Berman Group
New York
$1.4M +$22.4K +352 +1%
IRF
169
IBM Retirement Fund
New York
$1.39M +$1.54M +24,229 New
JMPWA
170
JP Morgan Private Wealth Advisors
California
$1.37M -$51.9K -817 -3%
M&T Bank
171
M&T Bank
New York
$1.35M -$440K -6,913 -23%
Squarepoint
172
Squarepoint
New York
$1.32M +$1.46M +23,000 New
CCA
173
Checchi Capital Advisers
California
$1.32M +$1.45M +22,859 New
ACM
174
Alpha Capital Management
Texas
$1.27M +$1.4M +22,051 New
WSA
175
Wall Street Associates
California
$1.26M -$394K -6,200 -22%
5 6
7
8 9

IONS Hedge Fund Activity: Q2 2015 in Review

353 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2015, worth a combined $5.72B — down 11% from $6.45B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new IONS positions and 43 closed out — a net gain of 15 holders — while 112 added to existing stakes and 119 trimmed.

The largest buyer was Vanguard Group, adding an estimated $36.1M. The largest seller was BlackRock Fund Advisors, cutting an estimated $126M.

  • 353 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2015, up from 339 in Q1 2015.
  • Funds reported $5.72B of Ionis Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
  • 58 funds opened new Ionis Pharmaceuticals positions in Q2 2015 and 43 closed out, a net change of +15 holders.
  • The largest Ionis Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $36.1M added.
  • The largest Ionis Pharmaceuticals seller in Q2 2015 was BlackRock Fund Advisors, an estimated $126M sold.

Based on aggregated 13F filings for Q2 2015.